Point72 Ventures

Point72 Ventures is a global venture capital firm and the independent investment arm of Point72, the asset management firm led by Steven A. Cohen. It invests primarily in fintech, artificial intelligence and machine learning, and enterprise technologies, while also backing companies in deep tech, healthcare, mortgage tech, and adtech across all growth stages. The firm operates from offices in New York City, Palo Alto, San Francisco, and Stamford, Connecticut, reflecting its cross-border reach and emphasis on data-driven software and scalable technology solutions. Founded in 2016, Point72 Ventures supports innovative startups through strategic capital and domain expertise.

Marta Andres-Terre

Investor

Brie Blumenthal

Associate

Noah Carr

Partner

Adam Carson

Partner

Pete Casella

Partner

Past deals in Ottawa

Turnstone Biologics

Series D in 2021
Turnstone Biologics is a clinical-stage biotechnology company focused on developing viral immunotherapies to improve cancer survival. Its lead candidate, RIVAL-01, combines three immunomodulators to stimulate immune activity and reprogram the tumor microenvironment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.